<!DOCTYPE html>
<html lang="en">
    <head>
        <title>Risk Stratification</title>
        <link href="https://fonts.googleapis.com/css?family=Cousine:700|Roboto+Slab" rel="stylesheet">
        <link rel="stylesheet" type="text/css" href="style.css">
    </head>
    <body>
        <h1>Risk stratification of patients with autoimmune rheumatic disease</h1> 
        <h2>Adapted from BSR website</h2>
        <form id="form">
            <div>
                <label for="factor-1">Corticosteroid dose of &geq;20mg (0.5mg/kg) prednisolone (or equivalent) per day for more than four weeks</label>
                <input type="checkbox" id="factor-1">
            </div>
            <div>
                <label for="factor-2">Corticosteroid dose of &geq;5mg prednisolone but &lt;20mg (or equivalent) per day for more than four weeks</label>
                <input type="checkbox" id="factor-2">
            </div>
            <div>
                <label for="factor-3">Cyclophosphamide at any dose orally or IV within last six months</label>
                <input type="checkbox" id="factor-3">
            </div>
            <div>
                <label for="factor-4">Rituxumab in the last 12 months</label>
                <input type="checkbox" id="factor-4">
            </div>
            <div>
                <label for="factor-5">One immunosuppressive medication*, biologic/monoclonal** or small molecule immunosuppressant***</label>
                <input type="checkbox" id="factor-5">
            </div>
            <div>
                <label for="factor-6">Two or more immunosuppressive medication*, biologic/monoclonal** or small molecule immunosuppressant***</label>
                <input type="checkbox" id="factor-6">
            </div>
            <div>
                <label for="factor-7">Any one or more of these: age &gt;70, Diabetes Mellitus, pre-existing lung disease, renal impairment, history of ischaemic heart disease or hypertension</label>
                <input type="checkbox" id="factor-7">
            </div>
            <div>
                <label for="factor-8">Hydroxychloroquine, Sulfalsalazine alone or in combination</label>
                <input type="checkbox" id="factor-8">
            </div>
        </form>
        <div id="result">

        </div>
        <script>
            const form = document.getElementById('form')
            const factors = [3, 2, 3, 3, 1, 2, 1, 0]
            const checkboxes = form.querySelectorAll('input[type=checkbox]')
            const resultDiv = document.getElementById('result')

            form.addEventListener('click', function () {
                var score = 0

                for (var i=0; i<checkboxes.length; i++) {
                    var checkbox = checkboxes[i]
                    score += (checkbox.checked ? 1 : 0) * factors[i]
                }

                if (score >= 3) {
                    resultDiv.innerHTML = 'Definite High Risk - Patients to shield/self-isolate for 12 weeks'
                    resultDiv.style.backgroundColor = "#c0392b"
                } else if (score === 2) {
                    resultDiv.innerHTML = 'Moderate Risk - Patients to self-isolate if other concerns or high risk circumstances. Maintain enhanced social distancing'
                    resultDiv.style.backgroundColor = "#ff9800"
                } else {
                    resultDiv.innerHTML = 'Low Risk - Patients to maintain enhanced social distancing'
                    resultDiv.style.backgroundColor = "#4caf50"
                }
            })
        </script>
        <p class="sub-text">* Immunosuppressive medications include: Azathioprine, Leflunomide, Methotrexate, Mycophenolate (mycophenolate mofetil or mycophenolic acid), ciclosporin, Tacrolimus, Sirolimus. It does NOT include Hydroxychloroquine or Sulphasalazine, either alone or in combination</p>
        <p class="sub-text">** Biologic/monoclonal includes: rituximab; all anti-TNF drugs (etanercept, adalimumab, infliximab, golimumab, certolizumab and biosimilar variants of all of these); Tociluzimab; Abatacept; Belimumab; Anakinra; Seukinumab; Ixekizumab; Ustekinumab; Sarilumumab; Canakinumab</p>
        <p class="sub-text">*** Small molecules includes: all JAK inhibitors &#8212; baracitinib, tofacitinib etc.</p>
    </body>
</html>
